Dr Martin Moore | Chief Executive Officer
Meissa Vaccines, Inc

Dr Martin Moore, Chief Executive Officer, Meissa Vaccines, Inc

Martin (Marty) Moore, Ph.D. is a cofounder and chief executive officer of Meissa Vaccines. Prior to cofounding Meissa, Dr. Moore was an Associate Professor at Emory University and director of the Emory Children’s Center for Childhood Infections and Vaccines (CCIV). Dr. Moore developed an RSV reverse genetics platform technology and novel strategies and methods for making vaccine candidates by synthetic biology. As applied to RSV vaccines, this technology was recognized as Emory University’s innovation of the year in 2013. Dr. Moore has more than 70 publications in virology, is co-inventor of 20 RSV-related technologies, and is a frequent national/international lecturer on RSV and vaccines.


December 4 - Main Congress Day 2 @ 14:30

A novel live attenuated RSV vaccine

last published: 14/Aug/19 15:15 GMT

back to speakers

Sign Up for Event Updates

Contact us

To sponsor or exhibit contact:
Oliver Breed
+44 (0)207 092 1156


To speak:
Lauren Sheppard
+44 (0)207 092 1211